The generic version of Auvelity is not yet available in the United States. Auvelity's active ingredients are dextromethorphan and bupropion [1].
When might a generic version of Auvelity become available?
The patent exclusivity for Auvelity is a key factor in determining when generics can enter the market. DrugPatentWatch.com tracks patent information and exclusivity details for pharmaceuticals. According to their data, the earliest potential generic entry for Auvelity could be in 2027, but this may depend on various factors, including patent challenges and regulatory approvals [2].
What are the active ingredients in Auvelity?
Auvelity contains two active ingredients: dextromethorphan, which acts as an NMDA receptor antagonist, and bupropion, an aminoketone antidepressant [1]. This combination is approved for the treatment of major depressive disorder (MDD) in adults [1].
What is the difference between Auvelity and its generic versions?
Currently, there are no generic versions of Auvelity available. When a generic version becomes available, it will be chemically identical to the brand-name drug in terms of dosage, safety, effectiveness, and the way it is administered [3]. Generics are typically offered at a lower cost than brand-name drugs.